The Human IgG Kappa MAb kit is designed for the fast quantification of human IgGs Kappa light chains.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein Quantification |
Sample Volume | 10 µL |
The Human IgG Kappa MAb kit is designed for the fast quantification of human IgGs Kappa light chains.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Drug discovery and bioprocess often require accurate quantification technologies to improve the productivity workflow. Current methods such as ELISA do not properly fit with such objectives as they require multiple sample-handling and protocol steps. The human IgG Kappa MAb kit enables a rapid quantification of human IgG Kappa light chains in cell supernatant. The assay is compatible with natural IgG as well as recombinant antibodies.
Application |
Protein Quantification
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Product Group |
Kit
|
Sample Volume |
10 µL
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Biologics
|
Target Species |
Human
|
Technology |
TR-FRET
|
Therapeutic Area |
Cardiovascular
Infectious Diseases
Metabolism/Diabetes
NASH/Fibrosis
Neuroscience
Rare Diseases
|
Unit Size |
500 Assay Points
|
The human IgG Kappa MAb kit is detected in a sandwich assay format using 2 different specific antibodies. The anti-(h)-IgG Kappa antibody is labelled with d2 (acceptor) and the anti(h)-Fc antibody is labelled with Eu3+-Cryptate (donor). The two antibodies bind to the (h)IgG Kappa present in the sample, thereby generating FRET. The specific signal modulates positively in proportion to (h)IgG Kappa.
The human IgG Kappa MAb assay features a streamlined protocol with only 1 incubation step after sample and IgG Kappa MAb detection reagents dispensing. This protocol requires a single two-hour incubation period at RT.
Detection limit | 0.8 ng/mL |
Dynamic range | 0.8 to 100 ng/mL |
Specificity | subclasses IgG1, IgG2, IgG3 & IgG4 |
Cross reactivity | 0% Human Lambda |
0% Mouse Kappa | |
<1% Human IgM |
Are you looking for resources, click on the resource type to explore further.
With over 200 different types of cancer, management relies on a variety of techniques such as chemotherapy, radiotherapy, and...
This guide provides you an overview of HTRF applications in several therapeutic areas.
We are here to answer your questions.